4-ANTIBODY AG
4-Antibody AG develops human antibody drug-discovery platform for generating antibody therapeutics focused on immuno-oncology. Its technology platform Retrocyte Display is designed to generate therapeutic antibody drug candidates incorporating human antibody libraries expressed in mammalian B-lineage lymphocytes. The company also develops preclinical checkpoint antibody programs targeting GITR, OX40, CTLA-4, PD-1, TIM-3, and LAG-3. 4-Antibody AG was founded in 2002 and is based in Basel, Switzerland.
4-ANTIBODY AG
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2002-01-01
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.4-antibody.com
Total Employee:
251+
Status:
Active
Contact:
+41616332260
Total Funding:
25.75 M CHF
Technology used in webpage:
SPF IPv6 Microsoft Azure DNS PHP Microsoft DNS Made Easy DNS DNS Made Easy Tiggee
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Interline Therapeutics
Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.
Current Employees Featured
Investors List
Grazia Equity
Grazia Equity investment in Series A - 4-Antibody AG
Life Sciences Partners
Life Sciences Partners investment in Series A - 4-Antibody AG
Advent Venture Partners
Advent Venture Partners investment in Series A - 4-Antibody AG
Life Sciences Partners
Life Sciences Partners investment in Seed Round - 4-Antibody AG
Grazia Equity
Grazia Equity investment in Seed Round - 4-Antibody AG
BioMedPartners
BioMedPartners investment in Seed Round - 4-Antibody AG
Mulligan BioCapital
Mulligan BioCapital investment in Seed Round - 4-Antibody AG
Official Site Inspections
http://www.4-antibody.com
- Host name: redirection.dnsmadeeasy.com
- IP address: 96.45.83.167
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "4-Antibody AG"
4-Antibody Company Profile 2024: Valuation, Investors ... - PitchBook
4-Antibody General Information Description. Operator of a biopharmaceutical company intended to generate antibody therapeutics focused on immuno-oncology. The company is a …See details»
4-Antibody AG - VentureRadar
4-Antibody AG is a Swiss biotechnology company concentrating on the development and optimization of human therapeutic antibodies by means of a new patented technology …See details»
4-Antibody AG - Funding, Financials, Valuation & Investors
4-Antibody AG develops human antibody drug-discovery platform for generating antibody therapeutics focused on immuno-oncology. Search Crunchbase. ... How much funding has this …See details»
4-Antibody AG - Basel, Switzerland - bionity.com
4-Antibody is a biopharmaceutical company with a powerful fully-human antibody drug-discovery technology platform. The Company is making this technology available to pharmaceutical …See details»
4-Antibody AG - Crunchbase
4-Antibody AG develops human antibody drug-discovery platform for generating antibody therapeutics focused on immuno-oncology.See details»
4-Antibody - Company Profile - Tracxn
Mar 10, 2024 4-Antibody - Antibody discovery and optimization platform for drug development. Raised a total funding of $20.6M over 2 rounds from 5 investors. 4-Antibody has 3177 …See details»
4-Antibody - Products, Competitors, Financials, Employees, …
4-Antibody is a biopharmaceutical company with a powerful fully-human antibody drug-discovery technology platform. Use the CB Insights Platform to explore 4-Antibody's full profile. 4 …See details»
4-Antibody AG - BioCentury Company Profiles - BCIQ
Nov 30, 2022 4-Antibody AG - BioCentury Company Profiles for the biopharma industrySee details»
4-Antibody - startupticker.ch
Jul 3, 2021 4-Antibody is a biopharmaceutical company with a powerful fully-human antibody drug-discovery technology platform. The Company is making this technology available to …See details»
Ludwig Cancer Research
Jan 29, 2013 4-Antibody is a biopharmaceutical company with a powerful fully-human antibody drug-discovery technology platform which is generating an emerging pipeline of antibody …See details»
4-Antibody - Pharmaceutical Business review
4-Antibody is a biopharmaceutical company with a fully-human antibody drug-discovery technology platform that generates a pipeline of antibody therapeutics. This proprietary …See details»
4-Antibody AG - Tech Stack, Apps, Patents & Trademarks
4-Antibody AG develops human antibody drug-discovery platform for generating antibody therapeutics focused on immuno-oncology.See details»
4-Antibody AG Forms Collaboration with Human Genome Sciences
Aug 16, 2011 4-Antibody is a biopharmaceutical company with a powerful fully-human antibody drug-discovery technology platform which is generating an emerging pipeline of antibody …See details»
The global landscape of approved antibody therapies
Sep 6, 2022 In this review, we collected data from the Umabs Antibody Therapies Database (Umabs-DB) , to make a statistical analysis of the antibodies approved by at least one drug …See details»
4-Antibody AG Meets First Milestone in Boehringer Ingelheim ...
4-Antibody’s first R&D collaboration with a major pharma partner, Boehringer Ingelheim, commenced in early 2010 and is a long-term collaboration to discover and to develop fully …See details»
4-Antibody AG - Contacts, Employees, Board Members
Organization. 4-Antibody AG . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. 4 …See details»
Section 22.3: Antibodies - Biology LibreTexts
Oct 15, 2024 Antibodies (also called immunoglobulins) are glycoproteins that are present in both the blood and tissue fluids. The basic structure of an antibody monomer consists of four …See details»
4-Antibody AG Forms Collaboration with Human Genome Sciences
Aug 16, 2011 BASEL, Switzerland--(BUSINESS WIRE)-- 4-Antibody AG today announced the signing of a collaboration agreement with Human Genome Sciences (HGS) to discover and …See details»
Agenus acquires 4-Antibody AG - 2014-01-13 - Crunchbase
Agenus acquires 4-Antibody AG on 2014-01-13 for an undisclosed amount. Search Crunchbase. Start Free Trial . Chrome Extension. ... 4-Antibody AG acquired by Agenus . Save . Summary. …See details»
ANA Patterns
Anti-Cell (AC) is used in ICAP coding of HEp-2 IFA patterns [3, 4]. Although the term anti-cellular antibody has been used in place of ANA by ICAP [2] and others [1], there is support for and …See details»